4-[(4-Methylpiperazin-1-yl) methyl] benzoic acid dihydrochloride CAS 106261-49-8 Imatinib Mesylate Dhexdhexaad Sare daahirnimo
Sahayda Ganacsiga Imatinib Mesylate iyo Dhexdhexaadiyayaasha la xidhiidha:
Imatinib Mesylate CAS: 220127-57-1
N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine CAS: 152460-09-8
N- (5-Amino-2-methylphenyl) -4- (3-pyridyl) -2-pyrimidinea CAS: 152460-10-1
4-[(4-Methylpiperazin-1-yl)methyl] benzoic acid dihydrochloride CAS: 106261-49-8
Magaca Kiimikada | 4-[(4-Methylpiperazin-1-yl) methyl] benzoic acid dihydrochloride |
La mid ah | Imatinib Mesylate Intermediate |
Lambarka CAS | 106261-49-8 |
Lambarka CAT | RF-PI229 |
Heerka Saamiyada | Kaydka dhexdiisa, Qiyaasta Waxsoosaarka Ilaa Tan |
Qaanuunka molecular | C13H20Cl2N2O2 |
Miisaanka Molecular | 307.22 |
Meesha dhalaalaysa | 305.0 ~ 307.0 ℃ |
Solubility | Ku milmay Biyaha |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Caddaan ilaa ku dhawaad cad budo ilaa Crystal |
Daahirnimada / Habka Falanqaynta | ≥98.0% (HPLC) |
Khasaare xagga qalajinta | ≤0.50% |
Hadhaaga dabka | ≤0.50% |
Wadarta wasakhda | ≤2.0% |
Xumaanta Keliga ah ee ugu badan | ≤1.0% |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | Dhexdhexaadiyaha Dawada ee Imatinib Mesylate (CAS: 220127-57-1) |
Xidhmada: Dhalo, boorsada bireed aluminium, durbaan kartoonada, 25kg/Drum, ama sida waafaqsan shuruudaha macmiilka.
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka, qoyaanka iyo cayayaanka.
Shanghai Ruifu Chemical Co., Ltd. waa soo saaraha iyo soo saaraha 4-[(4-Methylpiperazin-1-yl) methyl] benzoic acid dihydrochloride (CAS: 106261-49-8) oo tayo sare leh.Waxaawaa dhexdhexaad caadi ahaan ku jira isku-dhafka Imatinib Mesylate (CAS: 220127-57-1).Imatinib Mesylate waa tyrosine kinase inhibitor, oo aad u gaar ah BCR-ABL, daawada afka ah ee daaweynta bukaanka qaangaarka ah ee Philadelphia chromosome positive chronic myeloid leukemia (CML) ee marxaladda ba'an iyo noocyada qaarkood ee leukemia ba'an ba'an (ALL), la dedejiyey. marxaladda iyo marxaladda daba-dheeraada ka dib guuldarada daaweynta interferon.